Navigation Links
Bayer Initiates Phase III Trial of Investigational Inhaled Amikacin Solution (BAY41-6551T) in Mechanically Ventilated Patients with Gram-negative Pneumonia
Date:4/16/2013

WAYNE, N.J., April 16, 2013 /PRNewswire/ -- Bayer HealthCare Pharmaceuticals Inc. announced today that patient enrollment is underway in its global Phase III trial program to evaluate the efficacy and safety of adjunctive aerosolized BAY41-6551 versus aerosolized placebo in the treatment of intubated and mechanically ventilated patients with Gram-negative pneumonia receiving standard of care intravenous antibiotics.  BAY41-6551 consists of amikacin inhalation solution delivered by a Pulmonary Drug Delivery System (PDDS) developed by Nektar Therapeutics (NASDAQ: NKTR).

"Bayer continues to invest in research for potential treatment options for many difficult to treat diseases," said Pamela A. Cyrus , MD, Vice President and Head of U.S. Medical Affairs, Bayer HealthCare Pharmaceuticals.  "This study is designed to evaluate the effectiveness of a solution of amikacin formulated for inhalation, delivered through a proprietary drug delivery system, as an adjunctive therapy for Gram-negative pneumonia in intubated and mechanically ventilated patients."

About the Phase III INHALE Study Program
The global INHALE study program is comprised of two prospective, randomized, double-blind, placebo-controlled, multicenter studies to evaluate the safety and efficacy of BAY41-6551 as adjunctive therapy in intubated and mechanically-ventilated patients with Gram-negative pneumonia receiving standard of care intravenous antibiotics.  The study will enroll patients age 18 or above that have microbiologically-confirmed pneumonia caused by Gram-negative organisms.  INHALE will be a large multi-center global program involving centers in North America, South America, Europe, Japan, Australia and Asia.  For more information about th
'/>"/>

SOURCE Bayer HealthCare Pharmaceuticals Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Bayer Employees Named Rising Stars by Healthcare Businesswomens Association
2. Regeneron and Bayer Announce Co-Promotion Agreement With Santen For EYLEA® (aflibercept) Injection in Japan
3. Bayer Partnership Delivers Industry-First Dose Management Offering
4. Zacks Bull and Bear of the Day Highlights: Discover Financial Services, POSCO, AstraZeneca, Bayer and Takeda Pharmaceutical
5. U.S. FDA Grants Priority Review to the New Drug Application for Bayers Regorafenib to Treat Patients with Metastatic Colorectal Cancer
6. Bayer Submits New Drug Application for Regorafenib for the Treatment of Gastrointestinal Stromal Tumors (GIST)
7. Hagens Berman Sobol Shapiro LLP and Douglas & London P.C. Announce Proposed Class Action Settlement in Bayer Combination Aspirin Products Litigation
8. MediSapiens sapprête à fournir à Bayer HealthCare Pharmaceuticals une nouvelle application informatique en nuage pour analyser et visualiser les données génomiques multidimensionnelles
9. MediSapiens liefert neue Cloud-Computing-App zur Analyse und Visualisierung multidimensionaler Genomdaten an Bayer HealthCare Pharmaceuticals
10. MediSapiens to Provide Bayer HealthCare Pharmaceuticals With a New Cloud Computing Application to Analyze and Visualize Multi-Dimensional Genomics Data
11. Bayers Second Annual Virtual Walk for Hemophilia Raises Funds, Generates Excitement in the Hemophilia Community
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... 2015  Oncobiologics, Inc., a biotherapeutics company focused ... has completed the construction of its GMP commercial ... Cranbury, New Jersey . ... designed to utilize multiple technologies that enable rapid ... the use of the latest single-use technologies, the ...
(Date:5/4/2015)... Mass. , May 4, 2015   HeartWare International, ... less invasive, miniaturized circulatory support technologies that are revolutionizing the ... CEO, Doug Godshall , is scheduled to present at ... in Las Vegas on Thursday, May ... The live webcast of the Company,s presentation at the ...
(Date:5/4/2015)...  CytRx Corporation (Nasdaq: CYTR ), a ... today announced an interim analysis from its two ... with either gemcitabine or ifosfamide. Both studies combine ... doses of aldoxorubicin. The combinations appear to be ... level of aldoxorubicin (170 mg/m2), impressive tumor responses ...
Breaking Medicine Technology:Oncobiologics opens commercial launch manufacturing facility in Cranbury, New Jersey 2Oncobiologics opens commercial launch manufacturing facility in Cranbury, New Jersey 3HeartWare Presentation At Bank Of America Merrill Lynch 2015 Health Care Conference To Be Webcast 2CytRx Reports Aldoxorubicin Demonstrates Both Tumor Shrinkage and Improved Quality of Life in Chemotherapy Resistant Cancers 2CytRx Reports Aldoxorubicin Demonstrates Both Tumor Shrinkage and Improved Quality of Life in Chemotherapy Resistant Cancers 3CytRx Reports Aldoxorubicin Demonstrates Both Tumor Shrinkage and Improved Quality of Life in Chemotherapy Resistant Cancers 4CytRx Reports Aldoxorubicin Demonstrates Both Tumor Shrinkage and Improved Quality of Life in Chemotherapy Resistant Cancers 5CytRx Reports Aldoxorubicin Demonstrates Both Tumor Shrinkage and Improved Quality of Life in Chemotherapy Resistant Cancers 6CytRx Reports Aldoxorubicin Demonstrates Both Tumor Shrinkage and Improved Quality of Life in Chemotherapy Resistant Cancers 7
... Oct. 30 The Salisbury Post ... to promote prescription drug assistance for poor and uninsured patients. ... 1950s TV show "Leave It To Beaver." After retirement, his life ... gaining sixty 60 pounds. , "My doctor told me I ...
... Mich., Oct. 30 Stryker Corporation (NYSE: SYK ) ... dividend policy to adopt a quarterly payment schedule in lieu ... the Company,s Board of Directors has declared a cash transition ... shareholders of record at the close of business on November ...
Cached Medicine Technology:'Leave It To Beaver' Star Visits Kannapolis to Promote Prescription Assistance 2
(Date:5/4/2015)... 04, 2015 HHT is a rare ... While it can have seemingly mild symptoms like ... events. Hereditary Hemorrhagic Telangiectasia (HHT) is a hereditary ... lack normal capillary connections between an artery and a ... severe nosebleeds, but may also be present in the ...
(Date:5/4/2015)... May 04, 2015 In a continuing ... for substance absue, Per Wickstrom, the founder of Choices ... Lounge and the “Salute to the Oscars” celebration ... on the top floor of the luxurious Beverly Hilton ... top producer of sustainable product placement in TV and ...
(Date:5/4/2015)... Milton Hershey School® has named J. Anthony ... Year, recognizing his commitment to pediatric cancer research and ... MHS students. , “Dr. Graves is a tremendous example ... provided a top-notch education, a nurturing environment, and the ... Gurt ’85, president of MHS. “He is applying the ...
(Date:5/4/2015)... Each year, the Susan G. Komen organization hosts 5K ... breast cancer. This year, Dr. Mark Deutsch and his staff ... sponsor for the 25th annual Susan G. Komen Greater Atlanta ... Square Mall. , The Komen organization hopes have 10,000 participants ... Perimeter Plastic Surgery has not only taken on the role ...
(Date:5/4/2015)... California (PRWEB) May 04, 2015 Getting ... to manage their health is critical to achieving the ... and reducing costs, but this will require a shift ... change also demands that health systems move beyond their ... who took part in the third live meeting of ...
Breaking Medicine News(10 mins):Health News:Frequent Nosebleeds Can Be a Sign of a Rare Undiagnosed Disease - Cure HHT 2Health News:Frequent Nosebleeds Can Be a Sign of a Rare Undiagnosed Disease - Cure HHT 3Health News:Per Wickstrom Interviews TV and Film Star Carolyn Hennesy About Substance Abuse and Treatment 2Health News:Milton Hershey School Names 2015 Alumnus of the Year 2Health News:Perimeter Plastic Surgery Sponsors 2015 Susan G. Komen Greater Atlanta "Race for the Cure" 2Health News:AJMC’s ACO Coalition Explores the New Rules of Patient Engagement 2Health News:AJMC’s ACO Coalition Explores the New Rules of Patient Engagement 3Health News:AJMC’s ACO Coalition Explores the New Rules of Patient Engagement 4
... on keeping homes safe , , SATURDAY, Oct. 27 (HealthDay ... were treated at U.S. hospital emergency departments for head ... as ladders, steps, and showers, the federal Consumer Product ... head injuries suffered by people in their homes is ...
... up to $150,000 to relief agencies for recovery and ... rebuilding ... ) today announced that it is responding to the devastating,California fires with ... rebuilding efforts. "Our hearts go out to everyone affected by these ...
... Oct. 26 Chantel Christie, daughter of NBA,power ... the Metro TeenAIDS,Youth Ambassador for HIV/AIDS Awareness on ... officials will be in attendance. As the new,spokesperson ... to,the youth on HIV/AIDS Awareness and encourage youth ...
... study from the Johns Hopkins Childrens Center suggests that ... psychological functioning and well-being in children may fail to ... some of the most severe bladder conditions, such as ... children with such conditions manage to adapt and have ...
... 26 Paramount Acquisition Corp.,(OTC Bulletin Board: PMQC, PMQCU, ... 100% of the outstanding stock of B.J.K.,Inc., a New ... to a Stock Purchase Agreement, by and among Paramount, ... 1, 2007, as amended. Effective as,of the closing of ...
... BERKELEY HEIGHTS, N.J., Oct. 26 Genta,Incorporated (Nasdaq: ... McCaughey has,submitted her resignation from the Company,s Board ... since 2001. "As a noted author and ... the response to reduce hospital infections from,multiply resistant ...
Cached Medicine News:Health News:Stay Ahead of Head Injuries 2Health News:Eli Lilly and Company Aids California Recovery Effort 2Health News:Chantel Christie Named Youth Ambassador for HIV/AIDS Awareness by Metro TeenAIDS Organization 2Health News:Quality-of-life yardstick needed for children with serious urologic conditions, Hopkins study shows 2Health News:Paramount Completes Acquisition of Chem Rx 2Health News:Genta Announces Resignation of Dr. Betsy McCaughey from Board of Directors 2Health News:Genta Announces Resignation of Dr. Betsy McCaughey from Board of Directors 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: